RxDoctor Payments Data

Kimberly Hiser, APRN

Nurse Practitioner · Lincoln, NENPI 1639152572

Payments from drug & device makers

$1,758in general payments, 2019–2025

Across 135 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$888
  • AbbVie$297
  • Takeda Pharmaceuticals U.S.A., Inc.$237
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$190
  • Nestle Healthcare Nutrition Inc.$18
  • Gilead$18
  • plus $109 from 7 others

What the payments were for

  • Food & beverage$1,758100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,758 in reported general payments places this provider in the 80th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska

Medicare billing

Part B allowed, 2024
$60,706
Medicare patients
456
Services billed
877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin20$67,093
LinzessLinaclotide73$61,292
Mesalamine64$24,681
Mesalamine ErMesalamine59$9,961
Ursodiol45$8,197
Balsalazide Disodium43$7,432
Dexlansoprazole DrDexlansoprazole21$6,396
MovantikNaloxegol Oxalate19$6,000
Omeprazole464$5,974
Colestipol Hcl68$5,695
Pantoprazole Sodium414$5,320
Sucralfate57$3,634
Esomeprazole Magnesium50$3,059
Dicyclomine Hcl125$2,475
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate14$2,230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$190$67,09320 claims
AbbVieLinzess$297$61,29273 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 924 nurse practitioner providers in Nebraska.

Other nurse practitioner in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →